title: Clofarabine in relapsed lymphoma: what is the optimal dose?
authors: Chadi
authors: C
authors: Nabhan
mesh_terms: D000227:Adenine Nucleotides / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001087:Arabinonucleosides / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077866:Clofarabine; D003627:Data Interpretation, Statistical; D004334:Drug Administration Schedule; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008495:Medical Oncology / Q000379:methods; D012008:Recurrence; D012074:Remission Induction; D012107:Research Design
chemical_list: D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D001087:Arabinonucleosides; D000077866:Clofarabine